Glioblasztóma: vizsgálatok itt: Svájc
22 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 1. fázisTaking peopleAnti-GD2 ADC M3554 in Advanced Solid Tumors
- Where
- Zurich
- Életkor
- 18 év and over
- People
- 65 worldwide
- Run by
- EMD Serono Research & Development Institute, Inc.
See details and how to joinNCT06641908 · EU 2024-513687-26-00 - No phaseTaking peopleLeica Microsystems Sponsored PMCF Study to Collect and Confirm Clinical Data on the Performance of the GLOW400 Device When Used in Accordance With Its Intended Use
- Where
- Basel
- Életkor
- 18 év and over
- People
- 37 worldwide
- Run by
- Leica Microsystems (Schweiz) AG
See details and how to joinNCT07366892 - 2/3. fázisTaking peopleA Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
- Where
- Lausanne, Zurich
- Életkor
- 18 év and over
- People
- 2250 worldwide
- Run by
- Global Coalition for Adaptive Research
See details and how to joinNCT03970447 · EU 2024-511452-40-00 - 1/2. fázisTaking peopleA Study of Zedoresertib (Debio 0123) in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Zedoresertib (Debio 0123) in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
- Where
- Zurich
- Életkor
- 18 év and over
- People
- 116 worldwide
- Run by
- Debiopharm International SA
See details and how to joinNCT05765812 · EU 2022-502156-31-00 - 2. fázisTaking peoplePharmacoscopy for Patients With Refractory Primary Brain Tumors
- Where
- Basel, Sankt Gallen, Zurich
- Életkor
- 18 év and over
- People
- 40
- Run by
- University of Zurich
See details and how to joinNCT06804655 - 2. fázisTaking peopleVortioxetine for Newly Diagnosed Glioblastoma
- Where
- Zurich
- Életkor
- 18 év and over
- People
- 78
- Run by
- University of Zurich
See details and how to joinNCT07284628 - 1. fázisTaking peopleONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
- Where
- Zurich
- Életkor
- 2 év to 21 év
- People
- 208 worldwide
- Run by
- Sabine Mueller, MD, PhD
See details and how to joinNCT04732065 · EU 2025-521180-13-00 - 3. fázisTaking peopleLomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III Study
- Where
- Bellinzona, Zurich
- Életkor
- 18 év and over
- People
- 411 worldwide
- Run by
- European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT05904119 · EU 2023-505267-36-00 - No phaseTaking peopleLITT for Ultra-early GBM Recurrence
- Where
- Bern
- Életkor
- 18 év and over
- People
- 12
- Run by
- Insel Gruppe AG, University Hospital Bern
See details and how to joinNCT07616986 - 2. fázisTaking peopleEfficacy of the Combination of Trimipramine and Atezolizumab With Bevacizumab in Patients With Recurrent Glioblastoma: a Phase 2 Trial
- Where
- Aarau, Basel, Bern, Fribourg, Lausanne, Lucerne, Zurich
- Életkor
- 18 év and over
- People
- 59
- Run by
- Centre Hospitalier Universitaire Vaudois
See details and how to joinNCT07263438 - 2. fázisTaking peopleSurgery for Recurrent Glioblastoma
- Where
- Basel, Bern, Lausanne, Lugano
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Insel Gruppe AG, University Hospital Bern
See details and how to joinNCT02394626 - No phaseNot yet taking people in SvájcA Multicenter, Prospective Study for Glioblastoma Patients
- Where
- Bern
- Életkor
- 18 év and over
- People
- 100 worldwide
- Run by
- Larissa University Hospital
See details and how to joinNCT07162324 - No phaseTaking peopleRestrictive Use of Dexamethasone in Glioblastoma
- Where
- Basel, Bern, Sankt Gallen, Zurich
- Életkor
- 18 év to 90 év
- People
- 50
- Run by
- Insel Gruppe AG, University Hospital Bern
See details and how to joinNCT04266977 - No phaseTaking peopleResponse Assessment During MR-guided Radiation Therapy for Glioblastoma
- Where
- Zurich
- Életkor
- 18 év and over
- People
- 20
- Run by
- University of Zurich
See details and how to joinNCT05565326 - No phaseTaking peopleAdvanced Diffusion MRI to Differentiate Tumor Recurrence From Pseudoprogression in Patients With Glioblastoma and Brain Metastases
- Where
- Basel
- Életkor
- 18 év and over
- People
- 10
- Run by
- University Hospital, Basel, Switzerland
See details and how to joinNCT05911230 - 1/2. fázisTaking peopleGlutamate Inhibitors in Glioblastoma
- Where
- Zurich
- Életkor
- 18 év and over
- People
- 120
- Run by
- University of Zurich
See details and how to joinNCT05664464 - No phaseTaking peopleThe RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
- Where
- Bern
- Életkor
- 18 év to 90 év
- People
- 464 worldwide
- Run by
- Jasper Gerritsen
See details and how to joinNCT06283927 - No phaseTaking peopleThe SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
- Where
- Bern
- Életkor
- 18 év to 90 év
- People
- 784 worldwide
- Run by
- Jasper Gerritsen
See details and how to joinNCT06118723 - No phaseTaking peopleThe RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma
- Where
- Bern
- Életkor
- Up to 90 év
- People
- 225 worldwide
- Run by
- Erasmus Medical Center
See details and how to joinNCT06273176 - No phaseTaking peopleThe RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)
- Where
- Bern
- Életkor
- 18 év to 90 év
- People
- 564 worldwide
- Run by
- Jasper Gerritsen
See details and how to joinNCT06146725 - No phaseTaking peopleThe PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203)
- Where
- Bern
- Életkor
- 18 év to 90 év
- People
- 1015 worldwide
- Run by
- Jasper Gerritsen
See details and how to joinNCT06146738 - 1/2. fázisTaking peopleSafety and Efficacy of L19TNF Plus Temozolomide Chemoradiotherapy in Patients With Newly Diagnosed Glioblastoma
- Where
- Zurich
- Életkor
- 18 év and over
- People
- 226 worldwide
- Run by
- Philogen S.p.A.
See details and how to joinNCT04443010 · EU 2024-516357-46-00